Skip to main content

Search by Department


Additional NIH Doctors/Researchers

Meet Our Doctors


Portrait of Dr. Barbara Jean Bryant
Barbara Jean Bryant, MD, FCAP, FASCP

Chief, Department of Transfusion Medicine


Department of Transfusion Medicine
Center for Cellular Engineering


MD, University of Texas Medical Branch at Galveston
BS, Louisiana State University Medical Center New Orleans, Louisiana University of New Orleans


Email: Barbara.Bryant@nih.gov
Phone:301-594-8382

Portrait of Dr. Barbara Jean Bryant
Barbara Jean Bryant, MD, FCAP, FASCP

Chief, Department of Transfusion Medicine


Department of Transfusion Medicine
Center for Cellular Engineering


MD, University of Texas Medical Branch at Galveston
BS, Louisiana State University Medical Center New Orleans, Louisiana University of New Orleans


Email: Barbara.Bryant@nih.gov
Phone:301-594-8382


Dr. Barbara Jean Bryant became the chief of the Department of Transfusion Medicine and Center for Cellular Engineering at the NIH Clinical Center in January 2021.


Dr. Bryant has four decades of experience including 17 years in nearly every position possible in a Blood Bank before entering medical school.

Dr. Bryant's research endeavors and clinical interests have focused on maintaining optimal iron balance in blood donors, hemoglobinopathies, novel granulocyte therapies, patient blood management, and ensuring patient safety and best outcomes.

She received her bachelor's degree in medical technology from Louisiana State University Medical Center and the University of New Orleans. She earned her MD at UTMB, where she also completed a pathology residency and was chief resident for two years.

She did her fellowship training in Transfusion Medicine/Blood Banking at the NIH.

Dr. Bryant has served on the AABB Board of Directors, FDA Blood Product Advisory Committee, Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability working group (co-chair), and is the current past president of the South Central Association of Blood Banks.

Curriculum Vitae

Articles in Peer-Reviewed Journals

Nowak ES, Reyes DP, Bryant BJ, Cap AP, Kerstman EL, Antonsen EL. Blood transfusion for deep space exploration. Transfusion 2019;59:3077-3083.

Bryant BJ. Chartered planes, rescue trucks, and a Blackhawk. Transfusion 2018;58:842.

Rolon MR, Pacheco DA, Bryant BJ. Red to green pigment change noted in plasma of patient undergoing therapeutic plasma exchange for Goodpasture's syndrome. Transfusion 2018;58:2270-2271.

Cap AP, Beckett A, Cenov A, Borgman M, Chen J, Corley JB, Doughty H, Fisher A, Glassberg E, Gonzales R, Kane SF, Malloy WW, Nessen S, Perkins JG, Prat N, Quesada J, Reade M, Sailliol A, Spinella PC, Stockinger Z, Strandenes G, Taylor A, Yazer M, Bryant B, Gurney J. Whole Blood Transfusion. Military Medicine 2018; 183:44-51.

Esani MA, Arcari, CM, Mutambudzi M, Freeman VS, Bryant, BJ. Recommended interventions to reduce the risk of iron deficiency in blood donors. Texas Public Health Journal 2017;69:5-9.

Chansky M, King M, Bialkowski W, Bryant BJ, Kiss JE, D'Andrea P, Cable RG, Spencer BR, Mast AE. Qualitative assessment of pica experienced by frequent blood donors. Transfusion 2017;57:946-951.

Padmanabhan A, Jones C, Pechauer S, Curtis B, Bougie D, Irani M, Bryant BJ, Alperin J, DeLougehry R, Mulvey K, Dhakal B, Wen, R, Wang D, Aster R. Intravenous immunoglobulin for treatment of severe refractory heparin-induced thrombocytopenia. Chest 2017;152:478-485.

Cable RG, Birch RJ, Spencer BR, Wright DJ, Bialkowski W, Kiss JE, Rios J, Bryant BJ, Mast AE. The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in Blood Donors). Transfusion 2017;57:2440-2448.

Bialkowski W, Kiss JE, Wright DJ, Cable RG, Birch R, D'Andrea P, Bryant BJ, Spencer BR, Mast AE. Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in a longitudinal study. American Journal of Hematology 2017;92:851-857.

Mast AE, Bialkowski W, Bryant BJ, Wright DJ, Birch R, Kiss JE, D'Andrea P, Cable RG, Spencer BR. A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion 2016;56:1588-1597.

Bialkowski W, Bryant BJ, Schlumpf KS, Wright DJ, Birch R, Kiss JE, D'Andrea P, Cable RG, Spencer BR, Vij V, Mast AE. The strategies to reduce iron deficiency in blood donors (STRIDE) randomized trial: design, enrollment and early retention. Vox Sanguinis 2015;108:178-185.

Karafin MS, Denomme GA, Bryant BJ. The future of red blood cell alloimmunization risk reduction. Transfusion 2015;55:220-1.

Hill E, Bryant BJ. Comparison of antibody titers in donor specimens and associated AS-1 leukocyte-reduced donor units. Transfusion 2014;54:1580-1584.

Karafin MS, Bryant BJ. Transfusion medicine education: an integral foundation of effective blood management. Transfusion 2014;54:1208-1211.

Patel AJ, Wesley B, Leitman SF, Bryant BJ. Capillary versus venous hemoglobin determination in the assessment of healthy blood donors. Vox Sanguinis 2013;104:317-323.

Bates ST, Escobar RM, Moore TH, Bryant BJ. Refrigerators and freezers float; Irradiators & Transfusion 2013; 53:1626, cover.

Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Ascertainment of iron deficiency in routine blood donors through screening questions for pica and restless legs syndrome. Transfusion 2013;53:1637-1644.

Bryant BJ, Yau YY, Arceo SM, Daniel-Johnson J, Hopkins JA, Leitman SF. Role of iron replacement therapy in the routine management of blood donors. Transfusion 2012;52:1556-1575.

Lam R, Bryant BJ. Knowledge of FDA reportable deviations. Transfusion 2011;51:1619-1623.

Flynn R, Bryant BJ. Therapeutic phlebotomy procedures and their impact on a rural hospital's red cell inventory and fiscal stature. Transfusion 2011;51:2761-2766.

Hinojosa R, Bryant BJ. Leukocyte reduction filtration efficacy performed at varying time intervals post collection. Transfusion 2011;51:2758-2760.

Josefy SJ, Briones R, Bryant BJ. Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery. Immunohematology 2011;27:151-153.

Haywood J, Moulds MK, Bryant BJ. Determination of optimal method for antibody identification in a reference laboratory. Immunohematology 2011;27:146-150.

Bryant BJ, Yau YY, Byrne PJ, Stroncek DF, Leitman DF. Gravity sedimentation of granulocytapheresis concentrates with hydroxyethylstarch efficiently removes red cells and retains neutrophils. Transfusion 2010;50:1203-1209.

Gibble DM, Chaffin DJ, Bryant BJ. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center. Immunohematology 2010;25:170-173.

Klein HG, Bryant BJ. Pathogen-reduction methods: advantages and limits. ISBT Science Series Vox Sang 2009;4:154-160, cover.

Bryant BJ, Klein HG. Cyclosporine-induced microangiopathic hemolytic anemia during stem cell transplantation: Color-coordinated management by therapeutic plasma exchange and rifampin. Transfusion 2009;49:1291-1292.

Bryant BJ, Hopkins JA, Leitman SF. Evaluation of low red cell mean corpuscular volume in an apheresis donor population. Transfusion 2009;49:1971-1976.

Ackley R, Lee-Stroka H, Bryant B, Stroncek D, Byrne K. Cryopreserving and deglycerolizing sickle cell trait red blood cell components using an automated cell processing system. Immunohematology 2008;24:107-112.

Al-Rahawan MM, Alter BP, Bryant BJ, Elghetany MT. Bone marrow cell cycle markers in inherited bone marrow failure syndromes. Leukemia Research 2008;32:1793-1799.

Bryant BJ, Payne DA. Possible resistance: comparison of possible resistance results derived from a genotype report versus the IC50 virtual phenotype. Laboratory Medicine 2007;38:26-28.

Bryant BJ, Elghetany MT, Alperin JB. Paraplegia as the presenting manifestation of extramedullary megakaryoblastic transformation of previously undiagnosed chronic myelogenous leukemia. American Journal of Hematology 2007;82:150-154.

Bryant BJ, Klein HG. Pathogen inactivation - the definitive safeguard for the blood supply. Archives of Pathology and Laboratory Medicine 2007;131:719-733, cover.

Bryant BJ, Conry-Cantilena C, Ahlgren A, Felice A, Stroncek DF, Gibble J, Leitman SF. Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: tale of two cats. Transfusion 2007;47(11):1984-1989.

Bryant BJ, Bianchi M, Stroncek DF, Leitman SF. Leukoreduction filtration of whole blood units from sickle trait donors: effects of a metered citrate anticoagulant system. Transfusion 2007;47(12):2233-2241.

Allison RD, Bryant BJ, Vasu S, Leitman SF. Iron reduction and cardiovascular outcomes. J Am Med Assoc 2007;297:2075-2076(Letter).

Bryant BJ, Alperin JB, Indrikovs AJ. Blood bank on-call physician's experience at a large university medical center. Transfusion 2005;45:35-40.

Weber S, Bryant BJ, Indrikovs AJ. Sequestration of anti-Cra in the placenta: serological demonstration by placental elution. Transfusion 2005;45:1327-1330.

Raja V, Bryant B, Bessman JD, Alperin JB. Granulocytic sarcoma: presentation with nodal and skin involvement. Journal of Clinical Oncology 2004;22:2026-7.

Payne DA, Bryant BJ. HIV pharmacogenomics: closer to personalized therapy? American Journal of Pharmacogenomics 2004;4:141-50.

Abstracts

Booth AL, Bingham K, Guerra D, Bryant BJ, Yates S. Cost-minimization analysis before and after implementation of rapid bacterial testing at an academic medical center. Transfusion 2018;58:248A.

Lopert P, Aga G, Rice J, Bryant BJ, Irani M, Brooks S, Graminske S, Cancelas-Perez J, Rugg N. Apheresis platelets collected on Trima Accel and stored in InterSol platelet additive solution for 5 and 7 days are comparable to plasma-stored platelets in vitro. Transfusion 2018;58:147A-148A.

Joseph DM, Alperin JB, Bryant, BJ. Potential Evans syndrome in pregnancy. Texas Chapter of American College of Physicians Meeting 2017, Poster Presentation.

Booth AL, Vaidya S, Bryant BJ. Human leukocyte antigen typing in a profoundly leukopenic patient refractory to platelet transfusions. American Society of Clinical Pathology Annual Meeting 2017, Poster Presentation.

Wyble AJ, Kim YM, Bryant BJ. Diagnostic management teams in transfusion medicine. Transfusion 2017;57:211A.

Drouillard JS, Delvadia B, Milks K, Bryant BJ, Carterson A. Identification of a possible novel B subgroup in a pregnant female. Transfusion 2017;57:147A.

Wyble AJ, Alperin JB, Bryant BJ. Fat Embolism Syndrome versus Thrombotic Thrombocytopenic Purpura in Patients with Sickle Cell Disease - Red Cell Exchange versus Plasma Exchange. Transfusion 2016;56:83A.

Donnelly B, Brooks S, Bryant BJ, Graminske S, Heldke S, Johnson H, Kelher M, Kimpel N, Stanley C, Erickson A. Evaluation of a triple storage set at two U.S. blood Centers for the use with the Intercept Blood System for platelets in Intersol. Transfusion 2016;56:197-198A.

Padmanabhan A, Jones C, Pechauer S, Curtis B, Bougie D, Irani M, Bryant BJ, Alperin J, DeLougehry R, Mulvey K, Dhakal B, Wen, R, Wang D, Aster R. Intravenous immunoglobulin (IVIg) is a highly effective treatment for HIT: Critical role of the IgG Fc domain in inhibiting HIT antibody-mediated platelet activation. Blood 2016; 128:22.

Erickson A, Brooks S, Bryant BJ, Cancelas-Perez J, Graminske S, Hartman E, Heldke S, Johnson H, Kehler M, Kimpel N, Nestheide S, West FB, Rugg N, Stanley C, Donnelly B.  Qualification of 3 US blood centers for use of the Intercept System for platelets in 100% plasma. ISBT 2015, London.

Vinesett EM, Lalonde TL, Fang W, Bryant BJ. Platelet count as an indicator of iron status in plateletpheresis donors. American Association of Blood Banks National Meeting 2015, Top Poster. Transfusion 2015;55:88A.

Mast AE, Bialkowski W, Bryant BJ, Wright DJ, Birch R, Kiss JE, D'Andrea P, Cable RG, Spencer BR. Iron status of donors in STRIDE, a randomized, blinded, placebo-controlled study of education and iron supplementation for mitigation of iron deficiency in frequent blood donors. American Association of Blood Banks National Meeting 2015, Oral Presentation. Transfusion 2015;55:21A-22A.

Cable RG, Bialkowski W, Bryant BJ, Wright DJ, Birch R, Kiss JE, D'Andrea P, Spencer BR, Mast AE. Donor behaviors during participation in STRIDE a randomized, blinded, placebo-controlled study of education and iron supplementation for mitigation of iron deficiency in frequent blood donors. American Association of Blood Banks National Meeting 2015, Plenary Presentation. Transfusion 2015;55: 5A.

Shaz B, Bryant BJ, West BF, Huang N, Mathur A, Graminske S, Kelher M, Stanley C, Corash L, Erickson A. In vitro evaluation of platelets in PAS-3 prepared with the Intercept Blood System. Transfusion 2015;55:62A.

Le T, Bryant BJ, Cancelas J, Huang N, Kelher M, Stanley C, Graminske S, Rugg N, Corash L, Erickson A. In vitro evaluation of platelets in plasma prepared with the Intercept Blood System. Transfusion 2015;55:70A.

Hensch LA, Alperin JA, Bryant, BJ. Heparinoid syndrome: A rare cause of clinically significant coagulopathy. Transfusion 2014;54:185A.

Kent R, Spicer A, Bryant BJ. Evaluation of platelet progeny production during blood bank storage conditions. South Central Association of Blood Banks Meeting 2013, Oral Presentation.

Hill E, Bryant BJ. Comparison of antibody titers in donor specimens and associated AS-1 leukocyte-reduced donor units. South Central Association of Blood Banks Meeting 2013, Oral Presentation.

Watson B, Bryant BJ. Transfusion of group O red blood cells to non-group O recipients: analysis and assessment of practice. South Central Association of Blood Banks Meeting 2013, Poster Presentation.

Russell L, Woods C, Ivy K, Bryant BJ. Unexpected antibodies and leukocyte-reduction failures: Trends in red blood cell wastage. South Central Association of Blood Banks Meeting 2013, Poster Presentation.

Strong A, Uptmor C, Taylor E, Tebbetts K, Bryant BJ. An investigation of non-ABO group specific platelet transfusion practices in United States blood banks. South Central Association of Blood Banks Meeting 2013, Poster Presentation.

Gore P, Bryant BJ. Initiatives to Reduce Reaction Rates in Young Blood Donors. South Central Association of Blood Banks Meeting 2013, Poster Presentation.

Benson K, Bryant BJ. Impact of HLA antibody testing on female plateletpheresis donors to reduce the number of transfusion-related acute lung injuries. South Central Association of Blood Banks Meeting 2012, Poster Presentation.

Treat CJ, Scalia F, McQueen I, Sharks P, Bryant BJ. Thromboelastographic testing to determine individual response to clopidogrel. South Central Association of Blood Banks Meeting 2012, Poster Presentation.

O'Neil TA, Blackledge ED, Wabela NT, Bryant BJ. Correlation between hemoglobin F and the Kleihauer-Betke test. South Central Association of Blood Banks Meeting 2012, Poster Presentation.

Treat CJ, Scalia F, McQueen I, Sharks P, Bryant BJ. Thromboelastographic testing to determine individual response to clopidogrel. International Society of Thrombosis and Hemostasis, Annual Meeting 2012; Liverpool, UK, Poster Presentation.

Kent R, Spicer A, Bryant BJ. Evaluation of platelet progeny production during blood bank storage conditions. American Association of Blood Banks National Meeting 2012, Oral Presentation. Transfusion 2012;52:17-18A.

Russell L, Woods C, Ivy K, Bryant BJ. Unexpected antibodies and leukocyte-reduction failures: Trends in red blood cell wastage. Transfusion 2012;52:82-83A.

Strong A, Uptmor C, Taylor E, Tebbetts K, Bryant BJ. An investigation of non-ABO group specific platelet transfusion practices in United States blood banks. Transfusion 2012;52:69A.

Watson B, Bryant BJ. Transfusion of group O red blood cells to non-group O recipients: analysis and assessment of practice. Transfusion 2012;52:197A.

Hill E, Bryant BJ. Comparison of antibody titers in donor specimens and associated AS-1 leukocyte-reduced donor units. Transfusion 2012;52:145A.

Bryant BJ, Schlumpf K, Kiss J, Cable R, Spencer B, Vij V, Mast A. Enrollment data from the Strategies To Reduce Iron DEficiency (STRIDE) Study. American Association of Blood Banks National Meeting 2012, Oral Presentation. Transfusion 2012;52:30-31A.

Spencer B, Mast A, Kiss J, Cable R, Bryant BJ, Schlumpf K for the STRIDE Study Group. Prevalence of fatigue and correlation with iron status in the STRIDE study of frequent donors. Transfusion 2012;52:90A.

Bryant BJ, Yau YY, Arceo SA, Hopkins JA, Leitman SF. Ascertainment of iron depletion and deficiency in blood donors through screening questions for pica and restless legs syndrome. Blood 2012;120:279a.

Haywood J, Moulds MK, Bryant BJ. What method of antibody identification is best for a reference laboratory? South Central Association of Blood Banks and the California Blood Bank Society Meeting 2011, Poster Presentation.

Josefy SJ, Briones R, Bryant BJ. Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery. South Central Association of Blood Banks and the California Blood Bank Society Meeting 2011, Oral Presentation.

Hinojosa R, Bryant BJ. Leukocyte reduction filtration efficacy performed at varying time intervals post collection. South Central Association of Blood Banks and the California Blood Bank Society Meeting 2011, Poster Presentation.

Flynn R, Bryant BJ. Therapeutic phlebotomy procedures and their impact on a rural hospital's red cell inventory and fiscal stature. South Central Association of Blood Banks and the California Blood Bank Society Meeting 2011, Poster Presentation.

O'Neil TA, Blackledge ED, Wabela NT, Bryant BJ. Correlation between hemoglobin F and the Kleihauer-Betke test. Transfusion 2011:51:111A.

Bates ST, Moore T, Bryant BJ. Intrauterine and Exchange Transfusion When No Compatible Donor Blood is Available. Transfusion 2011:51:111-112A.

Benson K, Bryant BJ. Impact of HLA antibody testing on female plateletpheresis donors to reduce the number of transfusion-related acute lung injuries. Transfusion 2011;51:129A.

Ly TL, Moore T, Bryant BJ. Clinically significant delayed hemolytic transfusion reaction due to anti-M. Transfusion 2011;51:158-159A.

Treat CJ, Scalia F, McQueen I, Sharks P, Bryant BJ. Thromboelastographic testing to determine individual response to clopidogrel. Transfusion 2011;51:190A.

Gomez SN, Alperin JB, Russo WL, Bryant BJ. Management of large intentional overdose of enoxaparin with protamine sulfate. Blood 2011;118:4330.

Haywood J, Moulds MK, Bryant BJ. What method of antibody identification is best for a reference laboratory? Transfusion 2010;50:165-166a.

Josefy SJ, Briones R, Bryant BJ. Preoperative coagulation studies to predict blood component usage in coronary artery bypass graft surgery. Transfusion 2010;50:181a.

Hinojosa R, Bryant BJ. Leukocyte reduction filtration efficacy performed at varying time intervals post collection using the Fenwal Express System with Intergral Sepacell RS-2000 Filter. Transfusion 2010;50:80a.

Flynn R, Bryant BJ. Therapeutic phlebotomy procedures and their impact on a rural hospital's red cell inventory and fiscal stature. Transfusion 2010;50:236a.

Lam R, Bryant BJ. Knowledge of FDA reportable deviations. American Association of Blood Banks National Meeting 2009, Oral Presentation. Transfusion 2009;49:235a.

Gibble D, Bryant BJ. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center. Transfusion 2009;49:249a.

Bryant BJ, Wehbe RM, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Effect of body position on donor deferral rates due to low fingerstick hemoglobin. Transfusion 2009;49:60a.

Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Daniel-Johnson J, Bolan CD, Leitman SF.; Iron replacement therapy in the routine management of blood donors. Transfusion 2008;48:39a.

Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Ascertainment of iron deficiency and depletion in donors through screening questions for pica and restless legs syndrome. American Association of Blood Banks National Meeting 2008, Oral Presentation. Transfusion 2008;48:40a.

Yau YY, Leitman SF, Daniel-Johnson J, Gladden D, Bryant BJ, Bolan CD. Pre-donation fingerstick and venous hemoglobin levels vary significantly according to body position, but accurately predict an adequate red cell unit hemoglobin content regardless of position. American Association of Blood Banks National Meeting 2008, Oral Presentation. Transfusion 2008;48:67a.

Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF. Role of iron replacement therapy in the routine management of blood donors. BioIron, 2008.

Al-Rahawan M, Alter BP, Bryant BJ, Elghetany MT. Predictive markers of myelodysplastic syndrome in the bone marrow of patients with inherited bone marrow failure syndromes. Pediatric Academic Societies' Annual Meeting; 2007.

Alter BP, Al-Rahawan M, Bryant BJ, Elghetany MT. Predictive markers of myelodysplastic syndrome in the bone marrow of patients with Diamond-Blackfan anemia. Diamond-Blackfan Anemia Annual Meeting; 2007.

Elghetany MT, Al-Rahawan MM, Alter BP, Bryant BJ. Cell cycle and surface marker changes in the bone marrow of patients with Shwachman Diamond syndrome and other inherited bone marrow failure syndromes: comparison with acquired disorders. Shwachman Diamond Syndrome Annual Meeting; 2007.

Bryant BJ, Khuu HM, Uzel G, Holland SM, Leitman SF. Topical granulocyte concentrates for chronic wound healing in a patient with leukocyte adhesion deficiency-1. American Association of Blood Banks National Meeting 2007, Oral Presentation. Transfusion 2007;47:16a.

Bryant BJ, Hopkins JA, Leitman SF. Evaluation of low red cell mean corpuscular volume in an apheresis donor population. American Association of Blood Banks National Meeting 2007, Outstanding Poster. Transfusion 2007;47:45a.

Patel AJ, Bryant BJ, Wesley RA, Bolan CD, Leitman SF. Capillary versus venous hemoglobin determination in the eligibility assessment of healthy blood donors. American Association of Blood Banks National Meeting 2007, Outstanding Poster. Transfusion 2007;47:117a.

Bryant BJ, Leitman DF. Gravity sedimentation of granulocytapheresis concentrates with hydroxyethylstarch efficiently removes red dells and retains neutrophils. Transfusion 2007;47:84a.

Daniel-Johnson JA, Yau YY, Bryant BJ, Gladden D, Leitman SF, Bolan CD. Fingerstick hemoglobin varies markedly with changes in body position: comparison to venous hemoglobin. Transfusion 2007;47:12a.

Bryant BJ, Yau YY, Leitman, SF. Role of iron replacement therapy in the routine management of blood donors. European School of Haematology - Club du Globule Rouge et du Fer Euroconference, Disorders of Iron Homeostasis, Erythrocytes, and Erythropoiesis, Athens, Greece, 2007.

Harle M, Elghetany MT, Bryant BJ, Alter BP. Survivin staining of bone marrow biopsies may help understand cell cycle changes and differentiate inherited from acquired cytopenias: a study of 212 patients. Modern Pathology 2006;19:114.

Al-Rahawan M, Alter BP, Bryant BJ, Elghetany MT. Predictive markers of myelodysplastic syndrome in the bone marrow of patients with Fanconi anemia. 18th Annual International Fanconi Anemia Scientific Symposium; 2006.

Bryant BJ, Conry-Cantilena CC, Ahlgren A, Stroncek DF, Gibble J, Leitman SF.  Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors. Transfusion 2006;46:50a.

Al-Rahawan M, Alter BP, Bryant BJ, Elghetany MT. Predictive markers of myelodysplastic syndrome in the bone marrow of patients with Fanconi anemia. Blood 2006;108:297a.

Bryant BJ, Hopkins JA, Leitman SF. Evaluation of low mean corpuscular volume in as apheresis donor population. Blood 2006;108:114b.

Elghetany MT, Bryant BJ, Alter BP. Bone marrow expression of p53, Caspase-3, and WT-1 proteins in inherited and acquired cytopenias. Texas Society of Pathologists Annual Meeting; 2005.

Elghetany MT, Bryant BJ, Alter BP. Bone marrow expression of p53, caspase-3, and WT-1 proteins in inherited and acquired cytopenias: a study of 106 patients. Modern Pathology 2005;18:229a.

Elghetany MT, Bryant BJ, Alter BP. Bone marrow patterns of expression of p53, caspase-3, Ki 67, p21waf and WT-1 proteins may provide a tool to differentiate inherited from acquired cytopenias: a study of 199 patients. Blood 2005;106:302a.

Bryant BJ, Payne DA. Possible resistance: comparison of possible resistance results derived from a genotype report versus the IC50 virtual phenotype. International Conference on Cybernetics and Information Technologies, Systems and Applications 2004;2:31-33.

Bryant BJ, Weber S, Indrikovs AJ. Sequestration of anti-Cra in the placenta: serological demonstration by placental elution. Transfusion 2004;44:117a.

Bryant BJ, Elghetany MT. Paraplegia as the presenting manifestation of megakaryoblastic extramedullary blast crisis of previously unrecognized chronic myelogenous leukemia. American Journal of Clinical Pathology 2003;120:448.

Bryant BJ, Alperin JB, Indrikovs AJ. Blood bank on-call physician's experiences at a large university medical center. Transfusion 2003;43:110a.

Bryant BJ, Alperin JB, Indrikovs AJ. Exacerbation of thrombotic thrombocytopenic purpura due to Staphylococcus aureus septicemia. Transfusion 2002;42:38-39a.

Bryant BJ, Elghetany MT. Chronic myelogenous leukemia in extramedullary blast transformation of megakaryoblastic lineage presenting as paraplegia. Texas Society of Pathologists Meeting; 2001.

Bryant BJ, Alperin JB. Cambodian conundrum: an unrecognized case of hemoglobinopathy. Medical Student Clinical Vignette Competitions-Local (1st Place), State (1st Place) and National (Winner), American College of Physicians and American Society of Internal Medicine; 1999 - 2000.


  • Academy of Master Clinicians, March 2018
  • Keynote Speaker - Graduation and White Coat Ceremony. University of Texas Medical Branch, School of Health Professions, Clinical Laboratory Science Program, August 2018
  • Director, Academy of Master Clinicians, September 2018 - present
  • SCABB Technical Scientific Award Lecturer, SCABB Annual Meeting, May 2017
  • Presidential Cabinet Award Winner, 2016
  • Stubbins Memorial Award and Lecturer, University of Texas Medical Branch, March 2016
  • AABB 2016 Professional Engagement Program - Rising Star Award
  • AABB 2016 Sally Frank Memorial Award and Lectureship, AABB Annual Meeting, October 2016
  • Elected to UTMB Medical Staff Executive Committee, July 2012 - April 2013
  • Larry L. Trow Memorial Education Award, South Central Association of Blood Banks, April 2013
  • Roberto Logrono, MD Award for Professionalism in Medicine, Citation of Merit, University of Texas Medical Branch, April 2013
  • Texas Super Doctor, Rising Star Award, Texas Monthly, July 2013
  • Jack B. Alperin Award for Outstanding Support and Dedication to the Specialist in Blood Banking Technology Program, March 2012
  • Elected to UTMB Faculty Senate, July 2011
  • Keynote Speaker - Professionalism Ceremony. University of Texas Medical Branch, School of Health Professions, Clinical Laboratory Science Program, September 2011
  • Faculty Marshall, School of Medicine Commencement 2010
  • Best Clinical Pathology Faculty, 2009-1010
  • AABB-Fenwal Transfusion Medicine Scholarship Award, 2007
  • European Commission's Marie Curie Actions Scholarship, European School of Haematology - Club du Globule Rouge et du Fer Euroconference, Disorders of Iron Homeostasis, Erythrocytes, and Erythropoiesis, Athens, Greece, 2007
  • University of Texas Medical Branch 2nd Place Pathology Award for Applied/Clinical Research, 2005
  • Excellence in Teaching, 2003-2004, 2004-2005
  • Excellence in Patient Service, 2001-2002, 2002-2003, 2003-2004
  • University of Texas Medical Branch Outstanding First Year Resident, 2000-2001
  • AMWA's Janet M. Glasgow Achievement Citation, 2000
  • The L. Clarke Stout, Jr. Award for Excellence in Pathology, 2000
  • Winner in National Clinical Vignette Competition, 2000
  • Alpha Omega Alpha Medical Honor Society, 1999
  • First Place in University of Texas Medical Branch Clinical Vignette Competition, 1999
  • First Place in Statewide Clinical Vignette Competition, 1999
  • Dean's List, University of Texas Medical Branch, School of Medicine, 1997-1999

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 07/13/2021

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at http://www.cc.nih.gov/disclaimers.html